However, PD-L1, which is expressed at high levels on cancer cells, binds to PD-1 on T cells, resulting in inhibitory checkpoint signaling that inhibits their activation, thereby allowing unregulated tumor growth. This evidence concerns the gene PDCD1 and neoplasm.